This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Deloitte appoints David Hodgson as new Healthcare and Life Sciences partner

24 September 2012

Deloitte, the business advisory firm, has announced the appointment of David Hodgson as a healthcare and life sciences partner within its Audit Advisory practice.

With a proven track record in pharmaceuticals, David will strengthen the firm's risk advisory capabilities, with a particular focus on helping clients address their evolving regulatory obligations in a period of intense scrutiny.

David joins Deloitte from IMS Health, where he led the EMEA business transformation services team.  Previously, he was the managing partner of Accenture’s health & life sciences group for the UK and Ireland.

Simon Hammett, UK and EMEA healthcare and life sciences leader at Deloitte, said: “Governments and regulators are under increasing pressure to bring innovative medicines to market more quickly, whilst safeguarding and improving public health.  Within this context, the pharmaceutical industry has the opportunity to use smart regulatory activity to demonstrate its commitment to the achievement of good public health performance.”  

Simon Owen, Audit Advisory practice leader added: “David’s 18 years of experience in the pharmaceutical industry across business transformation, regulatory affairs and pharmacovigilance will be an asset to Deloitte as we continue to invest in our market leading risk advisory capabilities.”  

David Hodgson commented: “I am delighted to be joining Deloitte at a time when the industry and regulators are fundamentally rethinking how they approach the compliance environment. By helping clients adopt a risk intelligent approach there is an opportunity to balance the need for continued improvements in patient safety and faster access to new medicines whilst driving business performance and fostering growth.”  

Ends

Notes to editors:
About Deloitte

In this press release, references to Deloitte are references to Deloitte LLP, which is among the country's leading professional services firms.

Deloitte LLP is the United Kingdom member firm of Deloitte Touche Tohmatsu Limited (“DTTL”), a UK private company limited by guarantee, whose member firms are legally separate and independent entities. Please see www.deloitte.co.uk/about for a detailed description of the legal structure of DTTL and its member firms.

The information contained in this press release is correct at the time of going to press.

Member of Deloitte Touche Tohmatsu Limited

Media contacts

Name:
Ben Jun-Tai
Company:
Deloitte LLP
Job Title:
Phone:
020 7303 6989
Email
bjuntai@deloitte.co.uk
Name:
Celine Gordine-Wright
Company:
Deloitte LLP
Job Title:
Phone:
+44 (0) 20 7007 6384
Email
cgordinewright@deloitte.co.uk

Share this page

Email this Send to LinkedIn Send to Facebook Tweet this More sharing options
Follow:

Get in touch

More on Deloitte